Physician profile
Nirav N Shah
NPI 1306282439
$137,418.52
in general payments reported to CMS, 2019-2025
18 companies · $35K in 2025
The $35K reported for 2025 was more than what 99% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,911 · 2020: $9,643 · 2021: $18K · 2022: $27K · 2023: $23K · 2024: $20K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $53K · Travel and Lodging: $19K · Food and Beverage: $6,292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $53,127.00 |
| Travel and Lodging | $19,281.70 |
| Food and Beverage | $6,292.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $126,331.41 | 2019-2025 | Sprint Pns System |
| Vertiflex, INC. | $2,649.51 | 2019 | |
| Stryker Corporation | $1,709.00 | 2025 | |
| Nalu Medical, INC. | $1,244.82 | 2020-2025 | Nalu Neurostimulation System |
| Abbott Laboratories | $1,099.29 | 2019-2025 | Proclaim, Eterna |
| Vertos Medical, INC. | $944.65 | 2019-2024 | Mild Device Kit |
| Biotronik Nro, INC. | $853.68 | 2024-2025 | Prospera |
| Avanos Medical | $678.67 | 2019-2021 | |
| Relievant Medsystems, INC. | $496.48 | 2023 | Intracept |
| Nevro Corp. | $308.76 | 2019-2020 | |
| Boston Scientific Corporation | $231.09 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $227.51 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $175.01 | 2022-2024 | Exparel, Iovera, Zilretta |
| Saluda Medical Americas, INC. | $153.50 | 2023-2025 | Evoke, Evoke Scs |
| Vertex Pharmaceuticals Incorporated | $131.29 | 2024-2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $92.30 | 2024 | Intellis Adaptivestim |
| Merck Sharp & Dohme LLC | $51.60 | 2024-2025 | Bridion |
| Astellas Pharma US INC | $39.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirav Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.